November 16, 2015 | The Israel Biotech Fund, a new fund founded by Dr. Yuval Cabilly will receive investment of $50-100 million from Nasdaq-traded biomedical company Biogen, and Cabilly’s father, Dr. Shmuel Cabilly, a renowned oncologist and research scientist. According to Globes, the fund is intended to focus on Israeli biotech companies, an area of investment in which the Cabillys already have considerable experience.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments